Health Literacy and Digital Health in Cancer Patients. (LICAPA)

May 16, 2024 updated by: Institut Bergonié

This is a multicentric, prospective, observational, transversal study, aiming to evaluate the health literacy of cancer patients using the approved French version of the Functional, Communicative and Critical Health Literacy (FCCHL) scale in 2 populations:

  • Population A: patients age 65 and over treated in an oncology or oncogeriatric outpatient clinic, or seen in an oncology or oncogeriatric consultation.
  • Population B: young patients age 18 to 64 treated in an oncology or outpatient clinic, or seen in an oncology consultation.

The following questionnaires:

  • Approved French version of the FCCHL scale
  • Questionnaire on the use of digital tools adapted from the questionnaire on digital tools,

will be completed once only. It will be completed by the participant during the oncology or oncogeriatric consultation or outpatient clinic appointment, in self-questionnaire mode or face to face, assisted if necessary by a family member or member of the medical team.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Observational

Enrollment (Actual)

1518

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Paris, France
        • Pr Elene Paillaud

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Sampling Method

Probability Sample

Study Population

Patients seen in an oncology, or oncogeriatric consultation or treated in an oncology or geriatric outpatient clinic (not including full hospitalisation lasting ≥ 24h).

Description

Inclusion Criteria:

  1. Man or woman.
  2. Age ≥ 18 years.
  3. Patient treated for cancer.
  4. Patient who can read and understand French.
  5. Patient seen in an oncology or oncogeriatric consultation or treated in an outpatient clinic.
  6. Patient in treatment or about to start treatment that has been offered to them, from the announcement consultation to 2 years after the start of treatment

Exclusion Criteria:

  1. Patient hospitalised for longer than 24 hours.
  2. Patient with know cognitive impairment preventing them from answering the questionnaire.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Population A
65 years old and more
  • Approved French version of the FCCHL scale
  • Questionnaire on the use of digital tools adapted from the questionnaire on digital tools
Population B
18 to 64 years old
  • Approved French version of the FCCHL scale
  • Questionnaire on the use of digital tools adapted from the questionnaire on digital tools

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Percentage of Participants With an Overall Score of ≤ 4 on the FCCHL Scale.
Time Frame: 1 month

Health literacy of cancer patients using the approved French version of the Functional, Communicative and Critical Health Literacy (FCCHL) scale. The FCCHL questionnaire includes 14 items, divided into 3 sub-scales, reflecting 3 health literacy skills (functional literacy, interactive literacy and critical literacy). The overall score will be calculated by determining the mean score for the 3 sub-scales. A score of ≤ 4 on the FCCHL scale, corresponds to a low level of health literacy. Each item of the FCCHL takes a score of 1 to 5 points. For each patient, a literacy score per sub-scale will be determined by calculating the number of points divided by the number of items on the sub-scale. The score can range from 1 to 5. The overall literacy score will be calculated as the mean of the 3 sub-scales. This score can range from 1 to 5.

For functional scale, higher value represent worse outcome and for the other scale, a higher value represent a better outcome.

1 month

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Number et Percentage of Participants by Items of the Questionnaire on the Use of Digital Tools.
Time Frame: 1 month

The questionnaire on the use of digital tools will be described per item:

  • This questionnaire includes 10 items.
  • A Likert-type scale with five modalities of response is proposed (never, rarely, sometimes, often, always).
  • No overall score will be calculated.
1 month

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 27, 2021

Primary Completion (Actual)

November 8, 2021

Study Completion (Actual)

December 16, 2021

Study Registration Dates

First Submitted

September 23, 2021

First Submitted That Met QC Criteria

October 4, 2021

First Posted (Actual)

October 7, 2021

Study Record Updates

Last Update Posted (Actual)

June 12, 2024

Last Update Submitted That Met QC Criteria

May 16, 2024

Last Verified

October 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • IB 2021-04
  • 2021-A01725-36 (Other Identifier: ID-RCB number ANSM)

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cancer

Clinical Trials on Questionnaires

Subscribe